What Researchers Did
Researchers conducted a pilot case-controlled study comparing cerebrospinal fluid biomarkers in seven male divers with decompression sickness and seven age-matched controls.
What They Found
No significant differences were found in CSF markers for neuronal injury (total tau, neurofilament light), astroglial injury, or amyloid-beta metabolism between the seven DCS patients and seven controls. However, the single diver with central nervous system symptoms exhibited the highest levels of CSF total tau, Aβ38, Aβ40, and Aβ42.
What This Means for Canadian Patients
For Canadian divers experiencing decompression sickness without central nervous system symptoms, this study suggests there may not be widespread subclinical brain injury or amyloid accumulation. However, divers with neurological symptoms following DCS should be aware that their condition might be associated with elevated markers of neuronal injury and altered amyloid metabolism.
Canadian Relevance
This pilot study was not conducted in Canada and has no direct Canadian connection.
Study Limitations
A significant limitation of this pilot study is its very small sample size of only seven DCS patients and seven controls.